Table 3.
Short- term outcomes (at 2 months).
| Encephalitis (n = 20) | Aseptic meningitis (n = 46) | p-value | |
|---|---|---|---|
| Time to follow-up, daysb | 79 (60) | 62 (44) | 0.048 |
| No reported complaints (%) | 1/20 (5) | 17/46 (37) | 0.007 |
| Sick leave, total no (%) | 12/12 (100) | 16/43 (37) | <0.001 |
| 100% unable to work (%) | 7/12 (58) | 5/43 (12) | 0.002 |
| GOSE | |||
| GOSE <4 | 1 (5) | 0 | 0.007 |
| GOSE = 5–6 | 14 (74) | 18 (39) | |
| GOSE = 7–8 | 4 (21) | 28 (61) | |
| SF-36 subscores a | |||
| Physical functioning (PF) | 78.5 (21) | 89.3 (18) | ns |
| Role physical (RP) | 16.2 (32) | 45.2 (48) | 0.01 |
| Role emotional (RE) | 58.8 (42) | 77.4 (38) | ns |
| Bodily pain (BP) | 68.9 (28) | 65.7 (25) | ns |
| General health (GH) | 61.8 (21) | 66.6 (27) | ns |
| Vitality (VT) | 45 (15) | 51.1 (23) | ns |
| Social functioning (SF) | 61.8 (26) | 71.1 (31) | ns |
| Mental health (MH) | 73.2 (14) | 79.2 (15) | ns |
| Physical component summary (PCS) | 43.6 (8) | 46.7 (10) | ns |
| Mental component summary (MCS) | 45 (8) | 49 (11) | ns |
| HAD | |||
| HAD sum A, median | |||
| Sum 0–7, no of patients (%) | 15 (88) | 34 (79) | ns |
| Sum 8–10, no of patients (%) | 1 (6) | 5 (12) | ns |
| Sum 11–21, no of patients (%) | 1 (6) | 4 (9) | ns |
| HAD, sum D, median | ns | ||
| Sum 0–7, no of patients (%) | 16 (94) | 40 (93) | ns |
| Sum 8–10, no of patients (%) | 1 (6) | 2 (5) | ns |
| Sum 11–21, no of patients (%) | 0 | 1(2) | ns |
| Reported subjective complaints | |||
| Headache (%) | 6/20 (30) | 23/46 (50) | ns |
| Neck stiffness (%) | 0 | 4/44 (9) | ns |
| Photophobia (%) | 7/18 (39) | 8/46 (17) | ns |
| Phonophobia (%) | 7/18 (39) | 12/46 (26) | ns |
| Neurological symptomsc (%) | 13/20 (65) | 11/46 (24) | 0.001 |
| Concentration difficulties (%) | 12/20 (60) | 13/46 (28) | 0.015 |
| Memory problems (%) | 14 /20 (70) | 17/46 (37) | 0.013 |
| Emotional changed (%) | 7/18 (39) | 13/46 (28) | ns |
| Extensive tiredness (%) | 15/20 (75) | 18/46 (39) | 0.007 |
| Sleep disturbancee (%) | 14/20 (70) | 14/46 (30) | 0.003 |
Data are presented as number of patients (%), amean (SD) or bmedian (IQR). cMost reported were difficulty finding words, reduced coordination, urinary retention. dFeeling of anxiousness or mood disorder, eincreased need of sleep. GOSE: Glasgow Outcome Scale Extended, SF-36: Survey Short Form, HAD: Hospital Anxiety and Depression Scale.